The Case for Master Protocols for Rare Neurological Diseases

Jennifer Vermilion1, Sabrina Paganoni2,3, Scott R Plotkin4

  • 1Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.

Annals of Neurology
|July 21, 2026
PubMed
Summary

Master protocol trials can streamline testing for rare neurological diseases. This approach may accelerate the development of crucial therapeutics for conditions like neuronal ceroid lipofuscinoses.